Walleye Trading
OMED

Walleye Trading’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Walleye Trading’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,990
Closed -$67K – 5204
2018
Q1 		$67K Buy
+20,990
New +$57.8K ﹤0.01% 4059
2017
Q3 		– Sell
-88,826
Closed -$296 – 4976
2017
Q2 		$296 Buy
88,826
+84,226
+1,831% +$349K ﹤0.01% 2824
2017
Q1 		$42 Sell
4,600
-300
-6% -$2.63K ﹤0.01% 3855
2016
Q4 		$38K Buy
+4,900
New +$45K ﹤0.01% 3799

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Walleye Trading's OMED Position: Q2 2018 in Review

Walleye Trading sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2018, closing a stake of 20,990 shares — an estimated $67K sold.

Walleye Trading first reported a position in OMED in Q4 2016 and held it in 4 quarters. The position peaked at $67K in Q1 2018. 63 funds tracked by Wall St. Rank hold OMED as of Q2 2018.

  • Walleye Trading reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Walleye Trading sold 20,990 OncoMed Pharmaceuticals, Inc. shares in Q2 2018, an estimated $67K.
  • Walleye Trading first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
  • Walleye Trading's OncoMed Pharmaceuticals, Inc. position peaked at $67K in Q1 2018.
  • 63 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2018.

Based on Walleye Trading's 13F filing for Q2 2018, filed 14 Aug 2018.